Dapagliflozin Tablet, Film Coated
Product Images NDC 70377-024

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 70377-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dapagliflozin-10-mg-30s-syn (Dapagliflozin 10mg 30s Syn)

Each film-coated tablet contains Dapagliflozin butane-2, 3-diol monohydrate equivalent to Dapagliflozin 10 mg. The usual dosage and storage instructions can be found in the package insert. This medication is child-resistant and should be kept at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Manufactured by Biocon Pharma Inc. and dispensed in Iselin, NJ. This medication is produced by Syngene International Limited in India. Be sure not to use if the printed inner seal of the bottle is broken or missing. It is a package of 30 tablets.*

FDA Label Image

10mg 30count (Dapagliflozin 10mg 30s)

FDA Label Image

Dapagliflozin-5-mg-30s-syn (Dapagliflozin 5mg 30s Syn)

This is the description: Dapagliflozin tablets, each containing 5 mg of Dapagliflozin butane-2,3-diol monohydrate, with a child-resistant package and storage instructions. The medication guide should be provided with each dispensed package. Manufactured by Syngene International Limited in India for Biocon Pharma Inc., distributed in the USA. Batch serialization coding is included on the packaging for quality control.*

FDA Label Image

5mg 30count (Dapagliflozin 5mg 30s)

This text contains information about a medication called Dapagliflozin 5 mg, manufactured by Biocon Pharma Limited in India. The tablets are film-coated and packaged in a child-resistant container. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F). The package also includes a controlled room temperature medication guide. Make sure to keep this medication out of the reach of children and do not use it if the inner seal of the bottle is broken or missing.*

FDA Label Image

Dapagliflozin Figure 1 (Dapagliflozin Fig1)

This is a table showing CFB in 24-Hr Urinary Glucose levels and Dapagliflozin Dose with observed values for healthy subjects and subjects with T2DM. The chart also includes a fitted line for healthy subjects and those with T2DM.*

FDA Label Image

Dapagliflozin Chemical Structure (Dapagliflozin Struct)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

FDA Label Image

Figure4 (Fig4)

This text provides the number of patients at risk for a study comparing the effects of placebo and Dapagliflozin. It lists the number of patients who experienced an event for both treatment groups, along with the total number of patients at risk over different time points. This information is useful for understanding the outcome and impact of the treatments being examined in the clinical trial.*

FDA Label Image

Figure5 (Fig5)

This text appears to be a table showing the percentage of patients with events over different months from randomization for Dapagliflozin and Placebo. The number of patients at risk is also provided for both treatment groups at various time points.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.